Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

Known as adaptive deep brain stimulation, the implant constantly monitors and responds to brain activity to reduce the ...

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Enrollment ongoing in the United States for REGENERATE-PD clinical trial of AB-1005 ...

However, over a number of years, the brain of a Parkinson’s patient adapts to the levodopa treatment, and long term levodopa therapy can lead to dyskinesia, explained lead author Abhilasha ...

In fluctuating Parkinson's disease (PD) patients, treatment of PD using the catechol-O-methyl transferase inhibitor entacapone with carbidopa/levodopa improves quality of life and activities of ...

Phil Parkinson has previously managed Colchester United, Hull City, Charlton Athletic, Bradford City, Bolton Wanderers and Sunderland Speaking before his 1,000th game as manager, Wrexham boss Phil ...